LMNX Luminex Corporation featured news, full reports, and detailed charts
Luminex Corporation (LMNX) Wrap Up:
Luminex Corporation develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences industry. The life sciences industry depends on a broad range of tests, called bioassays, to perform diagnostic tests, discover and develop new drugs and identify genes. Our xMAP® technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 100 bioassays from a small sample volume, typically a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, digital signal processors and proprietary software to create a system offering advantages in speed, precision, flexibility and cost. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f14%2f0001362310-08-001423.html#FIS_BUSINESS"www.luminexcorp.com
384 Employees
Founded in 1995
Luminex Corporation (LMNX:NASDAQ)
LAST $13.92 USD
CHANGE TODAY +0.28 2.05%
VOLUME 433.0K
As of 4:00 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Luminex Corporation (LMNX)
|
OPEN
$13.58
|
PREVIOUS CLOSE
$13.64
|
|
|
DAY HIGH
$14.02
|
DAY LOW
$13.54
|
|
|
52 WEEK HIGH
12/11/08 - $24.14
|
52 WEEK LOW
11/13/09 - $12.75
|
|
|
MARKET CAP
581.8M
|
AVERAGE VOLUME 3 mo
576.1K
|
|
|
DILUTED EPS TTM
$-0.0094
|
SHARES OUTSTANDING
41.8M
|
|
|
LMNX Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
related news
LMNX: Initiated - JAGNote by William Blair
JAG Media - 11/18/2009 8:40 AM ET
LMNX Top Compensated Officers
Mr. Patrick J. Balthrop Sr.
Chief Executive Officer, President, Director,...
Age: 52
Total Annual Compensation: $521.4K
Mr. Harriss T. Currie
Chief Financial Officer, Principal Accounting...
Age: 47
Total Annual Compensation: $239.2K
Dr. Jeremy Bridge-Cook Ph.D.
Senior Vice President of Assay Group
Age: 40
Total Annual Compensation: $316.5K
Mr. David S. Reiter
Vice President, Corporate Secretary and Gener...
Age: 42
Total Annual Compensation: $216.4K
Mr. Russell W. Bradley
Vice President of Business Development & Stra...
Age: 45
Total Annual Compensation: $215.7K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for Luminex Corporation (LMNX)
Luminex Corporation expected to Report Fiscal Year 2009 Results on February 1, 2010. This event was calculated by Capital IQ (Created on November 9, 2009).
11/9/2009
Luminex Corporation expected to Report Fiscal Year 2009 Results on February 1, 2010. This event was calculated by Capital IQ (Created on November 9, 2009).
Luminex Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009 ; Revised Revenue Guidance for the Full Year of 2009
11/4/2009
Luminex Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported consolidated revenue of $29.1 million, 1% increase over the third quarter of 2008 revenue of $28.9 million. GAAP net loss was $0.6 million or $0.01 per share compared with GAAP net income of $3.2 million or $0.08 per share for the same period last year. Loss from operations was $0.5 million compared to income from operations of $3 million for the same period of last year. Loss before income taxes was $0.5 million compared to income before income taxes of $3.3 million for the same period of last year. Net cash provided by operating activities was $6.3 million compared to $3.7 million for the same period of last year. Purchase of property and equipment was $3.5 million compared to $0.9 million for the same period of last year. For the nine months, the company reported net loss $2.3 million or $0.06 per diluted share on revenue of $82.5 million compared to net income $1.1 million or $0.03 per diluted share on revenue of $76.3 million for the same period of last year. Income from operations was $2.1 million compared to income from operations of $1.2 million for the same period of last year. Loss before income taxes was $2.0 million compared to income before income taxes of $1.4 million for the same period of last year. Net cash used in operating activities was $0.7 million compared to net cash provided by operating activities of $7.9 million for the same period of last year. Purchase of property and equipment was $8.6 million compared to $2.8 million for the same period of last year. The company is adjusting 2009 full year revenue guidance to $118 to $126 million from between $118 and $132 million. The adjusted full year figures represent an increase of between 13% and 18% over reported 2008 revenue.
Luminex Corporation, Q3 2009 Earnings Call, Nov-04-2009
10/16/2009
Luminex Corporation, Q3 2009 Earnings Call, Nov-04 2009
LMNX Competitors
| Company | Last | Change |
| Caliper Life Sciences Inc | $2.70 USD | 0.00 |
| Celera Group | $6.25 USD | -0.05 |
| Cepheid | $13.37 USD | +0.10 |
| Nanosphere Inc | $6.26 USD | +0.13 |
| Sequenom Inc | $3.13 USD | +0.03 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | LMNX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 5.1x |
|
| Price/Book | 3.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 4.4x |
|
|
LMNX |
||
|
LMNX transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Luminex Corporation
More news for LMNX
Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2009
AUSTIN, Texas--(BUSINESS WIRE)--Luminex Corporation (NASDAQ:LMNX - News) today announced that it expects to report results for the third quarter of 2009 on Wednesday, November 4, 2009. A press release announcing the results is scheduled for release after the close of trading. Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2009, on November 4, 2009, at 5:00 p.m. Eastern time.The conference call will be webcast live and will be accompanied by a slide presentation, both of which may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call and slides will be archived for six months on the website using the 'replay' link....Click here to read the whole Article (external link)
Luminex Corporation Reports Third Quarter 2009 Results
LUMINEX CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Â Â Three Months Ended Nine Months ended September 30, September 30, 2009 Â 2008 2009 Â 2008 (unaudited) (unaudited) Cash flows from operating activities: Net income (loss) $ (609 ) $ 3,173 $ (2,287 ) $ 1,048 ...Click here to read the whole Article (external link)
Q3 2009 Luminex Corp Earnings Release - After Market Close
Earnings Announcements for Wednesday, November 4CompanySymbolTimeConferenceCall99 CENTS OnlyNDNAfter Market CloseAdept TechnologyADEPAfter Market CloseAffymax, Inc.AFFYBefore Market OpenAgilysys, Inc.AGYSBefore Market OpenAgrium Inc.AGUBefore Market OpenListenAlamo GroupALGAfter Market CloseALGOMA CENTRAL CORPALC.TOTime Not SuppliedALLIANCE BANKSHARES CORPABVAAfter Market CloseAllied Motion Technologies, Inc.AMOTTime Not SuppliedListenAlmost FamilyAFAMBefore Market OpenAlnylam PharmaceuticalsALNYAfter Market CloseListenAlon USA Energy Inc.ALJAfter Market CloseAlterian plcALN.LTime Not SuppliedAlvarionALVRBefore Market OpenListenAmbac Financial GroupABK08:30 am ETListenAmbassadors International, Inc.AMIEAfter Market CloseAmdocs LimitedDOX...Click here to read the whole Article (external link)
Luminex Corp Earnings Call scheduled for 5:00 pm ET today
Call DetailsLuminex Corp Earnings Conference Call (Q3 2009)Wed, Nov 4, 2009, 5:00 pm EasternAbout Luminex Corp (NasdaqGM:LMNX)Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences and diagnostic industries in the United States. It offers xMAP technology, an open architecture and multiplexing technology, which allows simultaneous analysis of up to 100 bioassays on a single drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company’s xMAP technology is used in various segments of the life sciences industry, which includes the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, protein analysis, and biomedical research. It operates in two segments, Technology and Assay. The Technology segment offers instruments, such as compact analyzers that integrate fluidics, optics, and digital signal processing; consumables comprising microspheres and sheath fluid; and LXR Software Developer’s Kit, a software interface for reading xMAP based assays on Luminex hardware. The Assay segment involves in the development and sale of assays on xMAP technology for use on Luminex’s installed base of systems. It offers kits, which are the combination of chemical and biological reagents, and the company’s proprietary bead technology used to perform diagnostic and research assays on samples. Luminex Corporation serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions. The company was founded in 1995 and is based in Austin, Texas.More Info:Quote |Chart |...Click here to read the whole Article (external link)
LUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition
Show all filings for LUMINEX CORP | Request a Trial to NEW EDGAR Online Pro Form 8-K for LUMINEX CORP 4-Nov-2009Results of Operations and Financial Condition Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not i...Click here to read the whole Article (external link)
Luminex Corporation Q3 2009 Earnings Call Transcript
Luminex Corporation (LMNX) Q3 2009 Earnings Call November 04, 2009; 05:00 pm ET Executives Pat Balthrop - President & Chief Executive Officer Harriss Currie - Chief Financial Officer Mimi Torrington - Director of Investor Relations Analysts David Clair - Piper Jaffray Doug Schenkel - Cowen & Co. Scott Gleason - Stephens Sung Ji Nam - JP Morgan Isaac Ro - Leerink Swann Derrick DeBruen - UBS Stephen Simpson - Northland Securities Herb Pathfinder - Wells Fargo Daniel Owczarski - Avondale Partners Patrick Donnelly - Thomas Weisel Partners Dan Leonard - First Analysis Dana Walker - Kalmar Investments. Matthew Scalo - Canaccord Adams Sanjay - JP Morgan Alastair Mckay - GARP Research & Securities Ashim Anhan - Unidentified Company Presentation Operator Good afternoon and welcome to the Luminex Corporation third quarter conference call. Today’s call is being recorded. At this time for opening remarks and introductions I would like to turn the call over to the Director of Investor Relations, Mimi Torrington; please go ahead ma’am. Mimi Torrington Thank you, Jessica. Good afternoon and welcome to Luminex Corporation’s conference call for the third quarter 2009, financial and operational results. I’m Mimi Torrington, Director of Investor Relations. Today, Pat Balthrop, our President and Chief Executive Officer; and Harriss Currie, our Chief Financial Officer will discuss our third quarter results highlights and the remaining outlook for 2009. Today we issued a press release announcing the company’s results for the third quarter ended September 30, 2009. Following o...Click here to read the whole Article (external link)
LUMINEX CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following information should be read in conjunction with the condensed consolidated financial statements and the accompanying notes included in Part I, Item 1 of this Report, and the "Risk Factors" included in Part II Item 1A of this Report and Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 (the "2008 10-K"). SAFE HARBOR CAUTIONARY STATEMENT This quarterly report on Form 10-Q contains statements that are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements give our current expectations of forecasts of future events. All statements other than statements of current or historical fact contained in this report, including statements regarding our future financial position, business strategy, new products, assay sales, budgets, liquidity, cash flows, projected costs, litigation costs, including the costs or impact of any litigation settlements or orders, regulatory approvals or the impact of any laws or regulations applicable to us, and plans and objectives of management for future operations, are forward-looking statements. The words "anticipate," "believe," "continue," "should," "estimate," "expect," "intend," "may," "plan," "projects," "will," and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements are based on our current plans and actual future activities, and our financial condition and results of operations may be materially different from those set forth in the forward-looking statements as a result of known or unknown risks and uncertainties, including, among other things: • risks and uncertainties relating to market demand and acceptance of our products and technology...Click here to read the whole Article (external link)
New Star Analyst Rankings for Luminex Corporation
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Copyright © 1999-2003, StarMine Corp. All rights reserved.StarMine Corp. derives analyst ratings from estimate and recommendation data supplied by Thomson Financial.Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and...Click here to read the whole Article (external link)
Luminex records loss in third quarter
ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | classifieds | view digital edition | ...Click here to read the whole Article (external link)
LUMINEX CORP Financials
PERIOD ENDING30-Sep-0930-Jun-0931-Mar-0931-Dec-08Total Revenue29,118 27,801 25,557 28,197 Cost of Revenue10,347 8,501 7,989 8,625 Gross Profit18,771 19,300 17,568 19,572 Operating ExpensesResearch Development5,643 4,977 4,626 4,729 Selling General and Administrative13,640 13,294 11,358 12,689 Non Recurring - - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss(512)1,029 1,584 2,154 Income from Continuing OperationsTotal Other Income/Expenses Net144 178 (4,079)515 Earnings Before Interest And Taxes(368)1,207 (2,495)2,669 Interest Expense116 124 118 186 Income Before Tax(484)1,083 (2,613)2,483 Income Tax Expense125 (29)177 474 Minority Interest - - - - Net Income From Continuing Ops(609)1,112 (2,790)2,009 Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - - - ...Click here to read the whole Article (external link)
Would you like to leave a comment about Luminex Corporation LMNX
Find out what social network information about Luminex Corporation are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Luminex Corporation there is more great information available at Realpennies.com